The
physiochemical properties of hydrogels utilized in 3D culture
can be used to modulate cell phenotype and morphology with a striking
resemblance to cellular processes that occur
in vivo
. Indeed, research areas including regenerative medicine, tissue
engineering,
in vitro
cancer models, and stem cell
differentiation have readily utilized 3D biomaterials to investigate
cell biological questions. However, cells are only one component of
this biomimetic milieu. In many models of disease such as Alzheimer’s
disease (AD) that could benefit from the
in vivo
-like
cell morphology associated with 3D culture, other aspects of the disease
such as protein aggregation have yet to be methodically considered
in this 3D context. A hallmark of AD is the accumulation of the peptide
amyloid-β (Aβ), whose aggregation is associated with neurotoxicity.
We have previously demonstrated the attenuation of Aβ cytotoxicity
when cells were cultured within type I collagen hydrogels
versus
on 2D substrates. In this work, we investigated the
extent to which this phenomenon is conserved when Aβ is confined
within hydrogels of varying physiochemical properties, notably mesh
size and bioactivity. We investigated the Aβ structure and aggregation
kinetics in solution and hydrogels composed of type I collagen, agarose,
hyaluronic acid, and polyethylene glycol using fluorescence correlation
spectroscopy and thioflavin T assays. Our results reveal that all
hydrogels tested were associated with enhanced Aβ aggregation
and Aβ cytotoxicity attenuation. We suggest that confinement
itself imparts a profound effect, possibly by stabilizing Aβ
structures and shifting the aggregate equilibrium toward larger species.
If this phenomenon of altered protein aggregation in 3D hydrogels
can be generalized to other contexts including the
in vivo
environment, it may be necessary to reevaluate aspects of protein
aggregation disease models used for drug discovery.